Laurion Capital Management’s Boston Scientific BSX Stock Holding History

Laurion Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-6,700	Closed	-$273K	–	915
2019 Q3	$273K	Buy	+6,700	New	+$284K	﹤0.01%	885
2018 Q4	–	Sell	-28,900	Closed	-$1.11M	–	1124
2018 Q3	$1.11M	Buy	+28,900	New	+$1.01M	0.01%	668
2018 Q1	–	Sell	-87,800	Closed	-$2.18M	–	1352
2017 Q4	$2.18M	Buy	87,800 +14,900	+20%	+$411K	0.01%	753
2017 Q3	$2.13M	Buy	72,900 +60,600	+493%	+$1.67M	0.01%	755
2017 Q2	$341K	Buy	+12,300	New	+$326K	﹤0.01%	1384

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Laurion Capital Management's BSX Position: Q2 2025 in Review

Laurion Capital Management sold out of Boston Scientific (BSX) in Q2 2025, closing a stake of 10,528 shares — an estimated $1.06M sold.

Laurion Capital Management first reported a position in BSX in Q3 2015 and held it in 21 quarters. The position peaked at $41.7M in Q2 2019. 1,688 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

Laurion Capital Management reported no remaining Boston Scientific position as of Q2 2025 after selling out during the quarter.
Laurion Capital Management sold 10,528 Boston Scientific shares in Q2 2025, an estimated $1.06M.
Laurion Capital Management first reported a position in Boston Scientific in Q3 2015 and held it in 21 quarters.
Laurion Capital Management's Boston Scientific position peaked at $41.7M in Q2 2019.
1,688 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Laurion Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.